Health Care • Biotechnology: Electromedical & Electrotherapeutic Apparatus
$49.37 ▼ -0.26
(-0.52%)
MKT CAP: $2.95B • VOL: 1.84M
52W L $23 52W H $53
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$41
MEDIAN
$55
MEAN
$56
HIGH
$67
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE AXGN TAPE
AXGN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $59.74 | $56.78 | 2025-02-14 | $44.93 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $62.21 | $58.26 | 2025-02-06 | $46.41 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $56.28 | $54.31 | 2025-01-29 | $47.40 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $50.36 | — | 2025-01-17 | $48.38 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $43.45 | $46.90 | 2025-01-09 | $43.94 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $58.75 | $51.34 | 2024-12-18 | $42.95 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $47.89 | $49.86 | 2024-12-04 | $45.91 | -4.3% | 48% | C |